본문 바로가기
KERD
논문KCI 등재

Limits of Monoclonal Antibody Treatment in Pregnant Women Complicated with COVID-19 Due to The Omicron Variant

0

조회

0

다운로드

0

인용

0

참고문헌

주제분류내과학

참고문헌 (8)

  1. Dougan M, "Bamlanivimab plus etesevimab in mild or moderate Covid-19", N Engl J Med, 385, pp.1382~1392 (2021)
  2. "Coronavirus disease 2019 (COVID-19) treatment guidelines"[URL]
  3. Kim Sun Bean, "Korean Society of Infectious Diseases", National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19, 2021, pp.53(2), 395~403[DOI]
  4. Chen C, "Who is providing contraception care in the United States? An observational study of the contraception workforce", Am J Obstet Gynecol, 226, pp.232~ (2022)
  5. "Coronavirus (COVID-19) update: FDA limits use of certain monoclonal antibodies to treat COVID-19 due to the omicron variant"[URL]
  6. Kim Min-Kyung, "Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea", Journal of Korean Medical Science, 37(3), pp.1~5 (2022), 대한의학회[DOI]
  7. "Guidelines for use of COVID-19 treatment"[URL]

관련 논문AI추천

이 간행물의 다른 논문 (24건)